Atossa Genetics Inc
Change company Symbol lookup
Select an option...
ATOS Atossa Genetics Inc
WHYRF West High Yield WHY Resources Ltd
TLLYF Trilogy International Partners Inc
DRRX DURECT Corp
LCI Lannett Company Inc
BDSI BioDelivery Sciences International Inc
ASRT Assertio Therapeutics Inc
ODP Office Depot Inc
FSD First Trust High Inc Long/Short Fund
CORR CorEnergy Infrastructure Trust Inc
Go

Health Care : Health Care Equipment & Supplies | Small Cap ValueCompany profile

Atossa Genetics Inc. is a clinical-stage pharmaceutical company focused on the development of therapeutics and delivery methods for the treatment of breast cancer and other breast conditions. The Company's leading program uses its intraductal microcatheters, which deliver pharmaceuticals through the breast ducts. It has initiated a Phase II clinical study using its microcatheters to deliver fulvestrant as a treatment of ductal carcinoma in-situ (DCIS) and breast cancer. Its second pharmaceutical program under development is Afimoxifene Topical Gel (AfTG) for the treatment and prevention of hyperplasia of the breast. It is also engaged in the process of evaluating other therapeutic candidates to treat other breast conditions, including breast cancer. Its medical devices include the ForeCYTE Breast Aspirator and the FullCYTE Breast Aspirator. These devices are intended for the collection of nipple aspirate fluid (NAF) for cytological testing at a laboratory.

Closing Price
$3.73
Day's Change
0.00 (0.00%)
Bid
--
Ask
--
B/A Size
--
Day's High
--
Day's Low
--
Volume
(Light)
Volume:
0

10-day average volume:
13,512,602
0
  • Prev Close
    3.73
  • Today's Open
    --
  • Day's Range
    --
  • Avg Vol (10-day)
    13.5M
  • Last (time)
    3:59p ET 03/21/19
  • Last (size)
    890
  • 52-Wk Range
    0.80 - 7.56
    LowHigh
  • (03/22/18 - 12/26/18)
    366.25%
  • 194.5%
  • Market Cap
    21.1M
  • Shares Outstanding
    5.6M
  • -7.46
  • --
  • No dividend
  • Ex-dividend
    No dividend
  • 4.0
  • 11.83
  • (% of float 02/28/19)
    8.41

Earnings Calendar and Events Data provided by |Terms of Use| © 2019 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2019. All rights reserved.